Pablo Stutzbach
Fundación Favaloro
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pablo Stutzbach.
Revista Espanola De Cardiologia | 2003
J. Horacio Casabé; Héctor Deschle; Claudia Cortés; Pablo Stutzbach; Alejandro Hershson; Claudia Nagel; Eduardo Guevara; Augusto Torino; Héctor Raffaelli; Roberto Favaloro; Luis D. Suárez
Introduction and objectives. The aim of this study was to describe the predictors of hospital mortality found in patients admitted for infective endocarditis (IE) to a cardiovascular surgery ward. Patients and method. Prospective study of 186 patients with IE treated in our hospital between 1992 and 2001. Results. One hundred fourteen patients (61.3%) had native valve endocarditis and 72 (38.7%) had prosthetic valve endocarditis (early in 28 patients [up to 12 months after surgery] and late in 44 [later than 12 months]). Blood cultures were positive in 82%. The predominant organism was Streptococcus viridans (36%) in native valve endocarditis and Staphylococcus aureus (33%) in prosthetic valve endocarditis. The hospital mortality was 22.6%. Severe sepsis (4.8%) produced a high mortality rate (88%) and was caused by Staphylococcus aureus in 60%. One hundred nineteen patients (64%) required surgery, 79 (66.4%) of them urgently. Negative blood cultures predicted need for surgery in native valve endocarditis (p < 0.05). The surgical mortality was 21.8% and was related to NYHA III-IV class (p = 0.014) and emergency surgery (p = 0.009) in patients with native valve endocarditis. This last factor also predicted higher surgical mortality in patients with early prosthetic valve endocarditis (p < 0.001). Conclusions. The hospital mortality of this group of patients with infective endocarditis treated in a tertiary medical center was high. The presence of severe sepsis, although infrequent, had a somber prognosis. Severe heart failure in native valve endocarditis and urgent surgery in native and prosthetic valve endocarditis increased surgical mortality.
The Annals of Thoracic Surgery | 1998
Ernesto Weinschelbaum; Pablo Stutzbach; Alejandro Machain; Roberto Favaloro; Victor Caramutti; Alejandro Bertolotti; Hugo Fraguas
BACKGROUND We analyzed in-hospital results of 87 patients undergoing minimally invasive valvular operations (right parasternal incision through third and fourth cartilages). METHODS Age was 21 to 84 years (mean, 56.2 +/- 16); 45 patients (51.7%) were female. Five (5.7%) had a previous valvular operation and 8 (9.2%) had severe left ventricular dysfunction. Valve diseases were as follows: aortic in 35 patients (40.2%), mitral in 44 (50.5%), double in 5 (5.7%), tricuspid regurgitation in 2 (2.2%), and mitral periprosthetic leak in 1 (1.1%). RESULTS Nineteen mitral repairs (21.9%), 22 replacements (25.3%), 1 leak closure (1.1%), 1 tricuspid repair (1.1%), and 1 replacement (1.1%) were performed. Thirty-one patients (35.7%) underwent aortic replacement, 2 (2.3%) aortic decalcification, 1 (1.1%) subaortic membrane resection, 4 (4.6%) a double-valve procedure, and 5 (5.7%) a single-valve operation combined with myocardial revascularization. In-hospital mortality was 5.7% (5 patients). Univariate analysis was significant for previous operation, New York Heart Association class IV and severe ventricular dysfunction. Multivariate analysis was significant for previous operation and severe ventricular dysfunction. Atrial fibrillation (12.6%) was the most frequent complication. Postoperative stay was 6.5 +/- 6 days. CONCLUSIONS The minimally invasive approach is a useful technique in valvular surgery. Patients with a previous valvular operation, severe ventricular dysfunction, and New York Heart Association class IV dyspnea have higher in-hospital mortality.
The Journal of Thoracic and Cardiovascular Surgery | 1999
Ernesto Weinschelbaum; Pablo Stutzbach; Martín Oliva; Javier Zaidman; Augusto Torino; Eduardo Gabe
OBJECTIVE We prospectively analyzed the short- and long-term results of manual debridement of the aortic valve in elderly patients with severe degenerative aortic stenosis. METHODS Between September 1988 and January 1997, 103 patients aged 73.7 +/- 6 years with degenerative aortic stenosis underwent the manual debridement technique. All had symptoms (angina or dyspnea, or both). Peak systolic gradient was 89 +/- 28 mm Hg. Forty-one patients (39.8%) had associated coronary artery disease necessitating revascularization. RESULTS Follow-up time was 42 +/- 21 months (range 3-98 months). The Kaplan-Meier estimated survival at 98 months was 50% (95% CI: 30%-70%). In-hospital mortality was 5.8% (6 patients), and late mortality was 21% (21 patients). No predictors of in-hospital mortality or of late mortality were detected. Nonfatal postoperative complications appeared in 25 patients (24%). At 8 years, freedom from endocarditis was 98% (95% CI: 95%-100%) and freedom from thromboembolic events was 99% (95% CI: 96%-100%). No patient required long-term anticoagulation as a result of the procedure. Fourteen patients (14%) required reoperation for aortic insufficiency (n = 5), restenosis (n = 8), and mitral regurgitation (n = 1). The probability of reoperation at 98 months was 23% (95% CI: 12%-35%). CONCLUSION Manual aortic valve debridement has low rates of in-hospital mortality, perioperative complications, and thromboembolic and infectious events and it offers freedom from anticoagulation. However, the incidence of restenosis and reoperation is high in the long term. It may therefore be regarded as an alternative in aged patients with favorable valve anatomy (no distortion and calcium deposits only on the aortic surface of the cusps), especially in those with a small aortic anulus, associated coronary artery disease, and/or contraindication for anticoagulation.
Journal of The American Society of Echocardiography | 2002
Miguel H. Bustamante‐Labarta; Sergio Perrone; Ricardo Leon de la Fuente; Pablo Stutzbach; Ricardo Pérez de la Hoz; Augusto Torino; Roberto Favaloro
Journal of the American College of Cardiology | 2006
Luis Cuniberti; Pablo Stutzbach; Eduardo Guevara; Gustavo G. Yannarelli; Rubén Laguens; Roberto Favaloro
Rev. argent. cardiol | 1999
Miguel Bustamante Labarta; Pablo Stutzbach; Eduardo Guevara; Ricardo Pérez de la Hoz; Mario O Fernández; Sergio Perrone; Augusto Torino; Luis D Suárez
Rev. argent. cardiol | 1999
Roberto Favaloro; Pablo Stutzbach; Victor Caramutti; Alejandro Machain; Carmen Gómez; J. Horacio Casabé; Martín Oliva; Mónica Alvarez
Rev. argent. cardiol | 1998
Ernesto Weinschelbaum; Pablo Stutzbach; Martín Oliva; Javier Zaidman; Augusto Torino; Eduardo Guevara; Eduardo Gabe
Prensa méd. argent | 2006
Luis Cuniberti; Eduardo Guevara; Gustavo Yannarelli; Pablo Stutzbach; Roberto Favaloro
Prensa méd. argent | 2005
Luis Cunibeti; Pablo Stutzbach; Eduardo Guevara; Gustavo G. Yannarelli; Fernando Brites; Roberto Favaloro